Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
37.76(c) 35.32(c) 35.82(c) 37.92(c) 38.76(c) Last
753 906 1 505 055 787 768 686 482 619 227 Volume
+5.09% -6.46% +1.42% +5.86% +2.22% Change
More quotes
Financials (USD)
Sales 2021 150 M - -
Net income 2021 -226 M - -
Net cash position 2021 340 M - -
P/E ratio 2021 -24,0x
Yield 2021 -
Sales 2022 211 M - -
Net income 2022 -249 M - -
Net cash position 2022 101 M - -
P/E ratio 2022 -22,4x
Yield 2022 -
Capitalization 5 438 M 5 438 M -
EV / Sales 2021 34,0x
EV / Sales 2022 25,2x
Nbr of Employees 622
Free-Float 98,4%
More Financials
Company
Adaptive Biotechnologies Corp is a biotechnology company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. It offers its immunoSEQ technology as a service and a kit. 
More about the company
Ratings of Adaptive Biotechnologies Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ADAPTIVE BIOTECHNOLOGIES CORPORATION
06/09New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine..
GL
06/03Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2..
GL
05/20Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Confer..
GL
05/07ADAPTIVE BIOTECHNOLOGIESá : Morgan Stanley Adjusts Adaptive Biotechnologies PT t..
MT
05/05ADAPTIVE BIOTECHNOLOGIES : Q1 Earnings Snapshot
AQ
05/05ADAPTIVE BIOTECHNOLOGIESá : First Quarter Earnings Presentation
PU
05/05ADAPTIVE BIOTECHNOLOGIESá : Management's Discussion and Analysis of Financial Co..
AQ
05/05ADAPTIVE BIOTECHNOLOGIESá : Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Posts..
MT
05/05ADAPTIVE BIOTECHNOLOGIES CORPá : Results of Operations and Financial Condition, ..
AQ
05/05Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
GL
04/27Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healt..
GL
04/12Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, ..
GL
03/17ADAPTIVE BIOTECHNOLOGIES CORPá : Change in Directors or Principal Officers, Regu..
AQ
03/17Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Dire..
GL
03/08SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Monday
MT
More news
News in other languages on ADAPTIVE BIOTECHNOLOGIES CORPORATION

- No features available -

More news
Analyst Recommendations on ADAPTIVE BIOTECHNOLOGIES CORPORATION
More recommendations
Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION
Duration : Period :
Adaptive Biotechnologies Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAPTIVE BIOTECHNOLOGIES CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 60,00 $
Last Close Price 38,76 $
Spread / Highest target 85,8%
Spread / Average Target 54,8%
Spread / Lowest Target 21,3%
EPS Revisions
Managers and Directors
NameTitle
Chad Robins Chairman & Chief Executive Officer
Julie Rubinstein President
Chad M. Cohen Chief Financial & Accounting Officer
Harlan Robins Chief Scientific Officer
Lance Baldo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ADAPTIVE BIOTECHNOLOGIES CORPORATION-34.45%5 438
EXACT SCIENCES CORPORATION-8.00%20 910
GUARDANT HEALTH, INC.-6.16%12 230
BGI GENOMICS CO., LTD.-7.00%7 659
INVITAE CORPORATION-25.33%6 239
CAREDX, INC25.95%4 750